The global Single-cell Analysis market size is expected to hit around US$ 8.7 billion by 2030 and is anticipated to grow at a CAGR of 16.0% during forecast period 2021 to 2030.
The global Single-cell Analysis market size is expected to hit around US$ 8.7 billion by 2030 and is anticipated to grow at a CAGR of 16.0% during forecast period 2021 to 2030.
Growth Factors
Expeditious technological advancements over the years have enabled a comprehensive analysis of transcriptome and genome in an individual cell.
Single-cell technology helps in assessing cellular heterogeneity and aids in the analysis of pathways and processes at the molecular level. This technology is evolving at a rapid pace with applications in oncology, immunology, and others. Moreover, the introduction of advanced devices that simplify transcriptomic and procedures is driving the market.
Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38286
Advances in single-cell RNA sequencing (scRNAseq) allow researchers to thoroughly investigate unexplored rare cell types. The development of the microfluidics method has significantly broadened the implementation of single-cell genomic/transcriptomic analysis in the biomedical field. A substantial number of microfluidic devices have been modified for cell dissociation and tissue digestion.
The increasing number of research publications is representative of the increasing investment flow in R&D in this market. As the R&D activities are the base of innovation, these investments signify a healthy growth possibility for this market. Moreover, researchers are engaged in assessing spatial heterogeneity in gene expression profiles at a single cellular level; thus, are anticipated to boost the uptake of consumables and instruments for the analysis.
Report Highlights
The consumables segment dominated the market and accounted for the largest revenue share of 58.1% in 2020 due to the high usability of products and frequent purchase of reagents, large-scale adoption of beads, and growing demand for assay kits. An increase in the prevalence of target diseases and the constant need for consumables required for the assays is propelling segment growth.
Moreover, reagents are consumables that are extensively used throughout cell analysis assays and hence the demand is always high. These reagents are available in different forms including multicolor cocktails, probes, markers, and phenotyping agents. As a result, the adoption and purchase of reagents lead to revenue generation in the market.
The cancer segment dominated the market and accounted for the largest revenue share of more than 31.0% in 2020. Single-cell analysis has proved to be effective for prior diagnostics of cancer cells, thus driving the segment. The mutation rates, proliferation conditions of cells, and cell types can be easily identified using these techniques.
The presence of a substantial number of research entities engaged in evaluating single-cell genomics and proteomics for the investigation of various therapeutic areas such as neuroscience, cancer, and infectious diseases has led to increasing adoption of single-cell analysis methods in diagnostics and therapeutic applications.
The single-cell isolation and library preparation segment dominated the market and accounted for the largest revenue share of 28.8% in 2020. Given the wide range of single-cell applications, the demand for cell isolation and library preparation products (kits and reagents) is also high. In addition, a substantial number of companies are offering products in this segment, in turn, augmenting revenue growth.
On the other hand, owing to technological advancements such as the emergence of next-generation sequencing for analyzing cell expressions, the downstream analysis segment is gaining traction over the past few years. Also, the market is witnessing an increasing adoption of machine learning and artificial intelligence in data analysis.
the academic and research laboratories segment dominated the market and accounted for the largest revenue share of over 71.0%. Single-cell analysis technology is being widely employed in research settings. The substantial number of ongoing research projects at universities that employ single-cell analysis assays have led to increased adoption of various single-cell analyses at research settings.
The advent of spatial genomics that accelerates the single-cell analysis in research settings is another key factor driving the segment growth. Academic researchers are engaged in assessing spatial heterogeneity in gene expression profiles at a single cellular level. Furthermore, single-cell transcriptomics is found to be useful for neuroscientists to understand cell types forming the brain.
Technological advancements such as the use of microfluidics for the development of next-generation therapies have increased the adoption of single-cell analysis by biotechnology and pharmaceutical companies. Moreover, increasing penetration of genomic technologies in drug development would further drive the market. A substantial number of pharma firms have invested in genomics to have an access to various genomics databases.
North America dominated the single-cell analysis market and accounted for the largest revenue share of 38.0% in 2020. This can be attributed to factors such as high government funding, rising personal healthcare expenditure, improved awareness, speedy adoption of novel analytical techniques, and the availability of skilled personnel.
The U.S. is the major contributor to the dominance of North America. Exceptionally developed healthcare infrastructure, rising expenditure on personalized medicine, growing awareness amongst citizens, and an increase in government and private funding for the research projects are some key driving factors for the market.
Key Players
- Thermo Fisher Scientific Inc.
- QIAGEN NV
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Merck Millipore
- Becton
- Dickinson & Company
- Fluidigm Corporation
- 10x Genomics, Inc.
- BGI
- Novogene Corporation
Market Segmentation
- Product Outlook
- Consumables
- Reagents
- Assay Kits
- Instruments
- Microscope
- Hemocytometers
- Flow Cytometers
- NGS Systems
- PCR
- High Content Screening Systems
- Cell Microarrays
- Single Live Cell Imaging
- Automated Cell Counters
- Consumables
- Application Outlook
- Cancer
- Immunology
- Neurology
- Stem cell
- Non-invasive prenatal diagnosis
- In-vitro fertilization
- Others
- Workflow Outlook
- Single Cell Isolation & Library Preparation
- Downstream Analysis
- Data Analysis
- End-use Outlook
- Academic & Research Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Others
- Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38286
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333